Low-Cost Tool for Compliance and Treatment-Tracking of Low Back Pain Patients

Overview

About this study

The purpose of this pilot phase study is to assess functionality and ease of use of an exercise monitoring system and decide whether any modifications are necessary before beginning a larger study using this system.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients must be ≥18 years old; and
  • Have chronic low back pain.

Exclusion Criteria: 

  • Patients with a high likelihood of being lost to follow-up or contact (e.g., patients with active chemical dependency) or are planning to move out of the state.
  • Patients with an inability to provide good data or follow commands (patients who are disoriented, have a severe neurologic or psychiatric condition).
  • Patients with an inability to do mild exercise (patients who have orthopedic-neurologic problems; patients who have severe heart failure; patients who should be at complete rest, confined to a bed or chair).
  • Patients with a history of spine surgery that includes instrumentation or hardware.
  • Patients who are taking opioid medication chronically without reasonable reduction in pain.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Kenton Kaufman, Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions